MYOS RENS Technology Announces the Date for the Release of First Quarter 2018 Results, Conference Call and Webcast

▤ Summary

The Company will announce earnings results for the first quarter ended March 31, 2018, prior to the conference call.A digital replay will be available by telephone approximately two hours after the completion of the call until July 31, 2018 and may be accessed by dialing 877-660-6853 from the U.S. or 201-612-7415 for international callers, using the Conference ID# 13679724.Fortetropin ® is a fertilized egg yolk based product manufactured via a proprietary process to retain and optimize its biological activity.Fortetropin ® has been clinically shown to increase muscle size and lean body mass in conjunction with resistance training.MYOS believes Fortetropin ® has the potential to redefine existing standards of physical health and wellness.

▦ Linked Companies